Studies on the hypoglycaemic compound cyclopropanecarboxylic acid. Effects on fatty acid oxidation in vitro.
D000090:Acetoacetates / Q000096:biosynthesis; D000143:Acids / Q000494:pharmacology*; D000818:Animals; D002087:Butyrates / Q000378:metabolism; D002210:Caprylates / Q000378:metabolism; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002264:Carboxylic Acids / Q000494:pharmacology; D002331:Carnitine / Q000378:metabolism; D003521:Cyclopropanes / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism*; D006168:Guinea Pigs; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010169:Palmitic Acids / Q000378:metabolism; D051381:Rats; D013045:Species Specificity; D014233:Tricarboxylic Acids / Q000378:metabolism
D000090:Acetoacetates; D000143:Acids; D002087:Butyrates; D002210:Caprylates; D002247:Carbon Isotopes; D002264:Carboxylic Acids; D003521:Cyclopropanes; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D010169:Palmitic Acids; D014233:Tricarboxylic Acids; D002245:Carbon Dioxide; D002331:Carnitine